# GCSF Adjunct Therapy for Biliary Atresia

> **NCT03395028** · EARLY_PHASE1 · COMPLETED · sponsor: **Holterman, Ai-Xuan, M.D.** · enrollment: 6 (actual)

## Conditions studied

- Biliary Atresia

## Interventions

- **DRUG:** Granulocyte Colony-Stimulating Factor

## Key facts

- **NCT ID:** NCT03395028
- **Lead sponsor:** Holterman, Ai-Xuan, M.D.
- **Sponsor class:** INDIV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03395028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03395028, "GCSF Adjunct Therapy for Biliary Atresia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03395028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*